HomeITCI • NASDAQ
add
Intra-Cellular Therapies Inc
Previous close
$66.53
Day range
$64.92 - $66.88
Year range
$45.50 - $84.89
Market cap
6.86B USD
Avg Volume
1.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 144.87M | 52.00% |
Operating expense | 113.08M | 14.32% |
Net income | -15.25M | 65.39% |
Net profit margin | -10.52 | 77.24% |
Earnings per share | -0.16 | 65.22% |
EBITDA | -20.82M | 56.86% |
Effective tax rate | -2.41% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 475.62M | -11.71% |
Total assets | 747.04M | 3.44% |
Total liabilities | 147.54M | 56.05% |
Total equity | 599.50M | — |
Shares outstanding | 105.57M | — |
Price to book | 10.82 | — |
Return on assets | -7.10% | — |
Return on capital | -8.56% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -15.25M | 65.39% |
Cash from operations | -34.12M | 43.20% |
Cash from investing | 16.18M | 198.28% |
Cash from financing | 9.99M | 174.42% |
Net change in cash | -7.95M | 89.10% |
Free cash flow | -32.91M | 24.50% |
About
Founded
2002
Website
Employees
610